BGA — BioNeutra Global Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$6.54m
- CA$12.85m
- CA$13.39m
- 47
- 76
- 43
- 55
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3.1 | -12.4 | -3.71 | -2.83 | -2.92 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 1.02 | 0.527 | 0.46 | 1 | 0.209 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.74 | 10.7 | 2.84 | 0.777 | 2.44 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 2.91 | 0.708 | 1.43 | 0.271 | 0.838 |
Capital Expenditures | -0.823 | -0.237 | -0.076 | -0.277 | -0.204 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0.516 | 0.05 | 0 | 0.006 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.823 | 0.278 | -0.026 | -0.277 | -0.197 |
Financing Cash Flow Items | -0.527 | -0.534 | -0.387 | -0.35 | -0.439 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.65 | -1.66 | -0.9 | -0.298 | -0.309 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.112 | -0.974 | 0.411 | -0.095 | -0.117 |